20 hrs ago
Will ImmunoGen's Q4 Earnings Disappoint Again?
ImmunoGen, Inc. will announce its fourth-quarter earnings and hold its annual fiscal year financial conference before the market opens on Friday, Aug. 1, 2014, at 8:00 a.m. EDT.
Immunogen Sets New 12-Month Low at $10.44
Immunogen 's share price hit a new 52-week low during trading on Friday , American Banking News reports.
Last week's biggest gainers and losers among Bay State biotechs
Last week was a tough one for publicly traded biotechs, with the Nasdaq Biotechnology Index losing 2.9 percent as new Federal Reserve Chairwoman Janet Yellen singled out biotech stocks as overvalued in comments to U.S. senators.
Friday's ETF Movers: XBI, GDXJ
In trading on Friday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 3.2% on the day.
ImmunoGen, Inc. Announces Conference Call to Discuss its Fourth...
ImmunoGen, Inc . , a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate technology, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, August 1, 2014, to discuss ImmunoGen's financial results for the three-month period and fiscal year ended June 30, 2014 and its ... (more)